Peter Atadja's Location

Boston, MA, US

Peter Atadja's Work

  • Director, Epigenetics Drug Discovery @ Novartis

Peter Atadja's Education

  • University of Calgary

    1991 - 1995
  • Hebrew University of Jerusalem

    Masters (Chemistry)

    1988 - 1991
  • Kwame Nkrumah University of Science and Technology

  • Kpando Secondary School

Peter Atadja's Skills

  • Research and Development
  • Clinical Trials
  • Drug Design
  • HPLC
  • Target Identification
  • Biotechnology
  • Immunology
  • Life Sciences
  • Validation
  • ADME

Peter Atadja's Summary

Peter Atadja, based in Boston, MA, US, is currently a Executive Director and Head, Drug Discovery at Novartis Institutes for Biomedical Research (Nibr), bringing experience from previous roles at Novartis. Peter Atadja holds a 1991 - 1995 University of Calgary. With a robust skill set that includes Research and Development, Clinical Trials, Drug Design, HPLC, Target Identification and more, Peter Atadja contributes valuable insights to the industry. Peter Atadja has 1 email on RocketReach.

Peter Atadja Email Address

Found 1 email address listing:

Arrow

5 free lookups per month.
No credit card required.

If you need more lookups, subscriptions start at $48 USD/month.

Redirecting you to the search page.

If you're not automatically redirected, please click here

Not the Peter Atadja you were looking for?

Find contact details for 700 million professionals.

Top Novartis Institutes for BioMedical Research (NIBR) Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users